156 related articles for article (PubMed ID: 23856266)
1. Calcimimetic and calcilytic drugs for treating bone and mineral-related disorders.
Nemeth EF; Shoback D
Best Pract Res Clin Endocrinol Metab; 2013 Jun; 27(3):373-84. PubMed ID: 23856266
[TBL] [Abstract][Full Text] [Related]
2. Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics.
Cook AE; Mistry SN; Gregory KJ; Furness SG; Sexton PM; Scammells PJ; Conigrave AD; Christopoulos A; Leach K
Br J Pharmacol; 2015 Jan; 172(1):185-200. PubMed ID: 25220431
[TBL] [Abstract][Full Text] [Related]
3. Physiology and pathophysiology of the calcium-sensing receptor in the kidney.
Riccardi D; Brown EM
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F485-99. PubMed ID: 19923405
[TBL] [Abstract][Full Text] [Related]
4. New insights into renal calcium-sensing receptor activation.
Dimke H
Curr Opin Nephrol Hypertens; 2024 Jul; 33(4):433-440. PubMed ID: 38690798
[TBL] [Abstract][Full Text] [Related]
5. G
Gorvin CM; Hannan FM; Howles SA; Babinsky VN; Piret SE; Rogers A; Freidin AJ; Stewart M; Paudyal A; Hough TA; Nesbit MA; Wells S; Vincent TL; Brown SD; Cox RD; Thakker RV
JCI Insight; 2017 Feb; 2(3):e91103. PubMed ID: 28194447
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies as negative allosteric modulators for human calcium sensing receptor.
Cui Q; Wang L; Wang H; Chen X; Han L; Geng T; Kou Y; Zhang W; Dai M; Qiao H; Sun Z; Li L; Lan Z; Xu H; Xu J; Dai Y; Geng Y
Biochem Biophys Res Commun; 2024 Feb; 695():149401. PubMed ID: 38154264
[TBL] [Abstract][Full Text] [Related]
7. Strontium is a biased agonist of the calcium-sensing receptor in rat medullary thyroid carcinoma 6-23 cells.
Thomsen AR; Worm J; Jacobsen SE; Stahlhut M; Latta M; Bräuner-Osborne H
J Pharmacol Exp Ther; 2012 Dec; 343(3):638-49. PubMed ID: 22942242
[TBL] [Abstract][Full Text] [Related]
8. Chronic Cinacalcet improves skin flap survival in rats: the suggested role of the nitric oxide pathway.
Akbariani M; Bidari Zerehpoosh F; Shahabi Z; Shadboorestan A; Hami Z; Nasiroleslami E; Shayesteh S; Chamanara M; Dehpour AR
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5005-5013. PubMed ID: 38183449
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations.
Howles SA; Hannan FM; Babinsky VN; Rogers A; Gorvin CM; Rust N; Richardson T; McKenna MJ; Nesbit MA; Thakker RV
N Engl J Med; 2016 Apr; 374(14):1396-1398. PubMed ID: 27050234
[No Abstract] [Full Text] [Related]
10. Discovery of a potent and short-acting oral calcilytic with a pulsatile secretion of parathyroid hormone.
Shinagawa Y; Inoue T; Katsushima T; Kiguchi T; Ikenogami T; Ogawa N; Fukuda K; Hirata K; Harada K; Takagi M; Nakagawa T; Kimura S; Matsuo Y; Maekawa M; Hayashi M; Soejima Y; Takahashi M; Shindo M; Hashimoto H
ACS Med Chem Lett; 2011 Mar; 2(3):238-42. PubMed ID: 24900301
[TBL] [Abstract][Full Text] [Related]
11. Small vs. Large Library Docking for Positive Allosteric Modulators of the Calcium Sensing Receptor.
Liu F; Wu CG; Tu CL; Glenn I; Meyerowitz J; Levit Kaplan A; Lyu J; Cheng Z; Tarkhanova OO; Moroz YS; Irwin JJ; Chang W; Shoichet BK; Skiniotis G
bioRxiv; 2024 Mar; ():. PubMed ID: 38234749
[TBL] [Abstract][Full Text] [Related]
12. The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases.
Das S; Clézardin P; Kamel S; Brazier M; Mentaverri R
Front Oncol; 2020; 10():69. PubMed ID: 32117726
[TBL] [Abstract][Full Text] [Related]
13. Dual Action Calcium-Sensing Receptor Modulator Unmasks Novel Mode-Switching Mechanism.
Gregory KJ; Kufareva I; Keller AN; Khajehali E; Mun HC; Goolam MA; Mason RS; Capuano B; Conigrave AD; Christopoulos A; Leach K
ACS Pharmacol Transl Sci; 2018 Nov; 1(2):96-109. PubMed ID: 32219206
[TBL] [Abstract][Full Text] [Related]
14. Calcimimetic and Calcilytic Drugs: Feats, Flops, and Futures.
Nemeth EF; Goodman WG
Calcif Tissue Int; 2016 Apr; 98(4):341-58. PubMed ID: 26319799
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulators of the extracellular calcium receptor.
Nemeth EF
Drug Discov Today Technol; 2013; 10(2):e277-84. PubMed ID: 24050279
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of the calcium sensing receptor.
Filopanti M; Corbetta S; Barbieri AM; Spada A
Clin Cases Miner Bone Metab; 2013 Sep; 10(3):162-5. PubMed ID: 24554924
[TBL] [Abstract][Full Text] [Related]
17. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
Marcocci C; Bollerslev J; Khan AA; Shoback DM
J Clin Endocrinol Metab; 2014 Oct; 99(10):3607-18. PubMed ID: 25162668
[TBL] [Abstract][Full Text] [Related]
18. Physiology. Calcilytics for asthma relief.
Penn RB
Science; 2015 Apr; 348(6233):398-9. PubMed ID: 25908810
[No Abstract] [Full Text] [Related]
19. AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women.
John MR; Harfst E; Loeffler J; Belleli R; Mason J; Bruin GJ; Seuwen K; Klickstein LB; Mindeholm L; Widler L; Kneissel M
Bone; 2014 Jul; 64():204-10. PubMed ID: 24769332
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of the calcilytic ligand NPS 2143.
Johansson H; Cailly T; Rojas Bie Thomsen A; Bräuner-Osborne H; Sejer Pedersen D
Beilstein J Org Chem; 2013; 9():1383-7. PubMed ID: 23946832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
